KD Logo

Viridian Therapeutics Inc [VRDN] Director makes an insider purchase of 476,190 shares worth 10.0 million.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viridian Therapeutics Inc shares valued at $9,999,990 were purchased by Fairmount Funds Management LLC on Jan 22 ’24. At $21.00 per share, Fairmount Funds Management LLC acquired 476,190 shares. The insider’s holdings grew to 1,839,954 shares worth approximately $22.54 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As published in their initiating research note from Wolfe Research on June 11, 2024, Viridian Therapeutics Inc [VRDN] has been an Outperform and the price target has been revised to $29. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of May 09, 2024, Ladenburg Thalmann has decreased its “Buy” rating to a “Neutral” for VRDN. Earlier on May 09, 2024, B. Riley Securities downgraded its rating. Their new recommendation was “a Neutral” for VRDN stock which previously was a “a Buy”.

Analyzing VRDN Stock Performance

During the last five days, there has been a drop of approximately -0.49%. Over the course of the year, Viridian Therapeutics Inc shares have dropped approximately -43.76%. Shares of the company reached a 52-week high of $24.18 on 01/09/24 and a 52-week low of $11.40 on 06/04/24. A 50-day SMA is recorded $13.10, while a 200-day SMA reached $16.23. Nevertheless, trading volume fell to 0.4 million shares from 0.65 million shares the previous day.

Support And Resistance Levels for Viridian Therapeutics Inc (VRDN)

According to the 24-hour chart, there is a support level at 11.85, which, if violated, would cause prices to drop to 11.46. In the upper region, resistance lies at 12.64. The next price resistance is at 13.04. RSI (Relative Strength Index) is 44.95 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.07, which suggests the price will decrease in the coming days. Percent R is at 66.97%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular